Frontier Bio is a startup based in the United States, 2 tracked investors.
Frontier Bio is a company headquartered in the United States. Brouky records 2 investors associated with the company.
Frontier Bio develops engineered human tissues and vascular grafts using advanced 3D bioprinting and tissue engineering technologies to create human tissue models for drug screening, disease modeling, and to reduce the need for animal testing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.